Forecast & Rating18 analysts currently cover BEONE MEDICINES, with about 94.4% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$263.47, about 17.4% upside from the current price of HK$224.40. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 64.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study BEONE MEDICINES closely still see room for the stock to rise. Data as of Aug 28, 2026; for reference only and not investment advice.
Aug 20, 2026Price forecast
HK$263.4717.41%
Forecast & RatingStrong buy
18analysts
- Strong buy77.78%
- Buy16.67%
- Hold5.56%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met52.1%
Stock price$224.40
Avg. target$263.5
High target$322
Low target$226
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.